🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Bio Path Holdings Inc (BPTH)

NASDAQ
Currency in USD
Disclaimer
0.871
-0.029(-3.33%)
Closed
After Hours
0.892+0.021(+2.411%)
BPTH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.8700.900
52 wk Range
0.85921.600
Prev. Close
0.9
Open
0.9
Day's Range
0.87-0.9
52 wk Range
0.859-21.6
Volume
13,998
Average Vol. (3m)
336,866
1-Year Change
-87.97%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
BPTH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
20.000
Upside
+2,196.211%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Bio Path Holdings Inc Company Profile

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.

Compare BPTH to Peers and Sector

Metrics to compare
BPTH
Peers
Sector
Relationship
P/E Ratio
−0.2x−1.1x−0.6x
PEG Ratio
0.000.000.00
Price / Book
1.7x−0.1x2.6x
Price / LTM Sales
-5.0x3.2x
Upside (Analyst Target)
2,196.2%22.4%41.1%
Fair Value Upside
Unlock−16.3%5.9%Unlock

People Also Watch

0.901
MBOT
+0.00%
1.820
GANX
+5.81%
13.5700
WHLR
-18.35%
0.429
ENVB
+2.37%
1.160
INDP
-0.85%

FAQ

What Is the Bio Path (BPTH) Stock Price Today?

The Bio Path stock price today is 0.871

What Stock Exchange Does Bio Path Trade On?

Bio Path is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Bio Path?

The stock symbol for Bio Path is "BPTH."

What Is the Bio Path Market Cap?

As of today, Bio Path market cap is 2.22M.

What is Bio Path Earnings Per Share?

The Bio Path EPS is -13.74.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.